Yau Patricia, Xia Yu, Shariff Saadat, Jakobleff William A, Forest Stephen, Lipsitz Evan C, Scher Larry A, Garg Karan
Division of Vascular Surgery, Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center, Bronx NY.
Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center, Bronx NY.
Ann Vasc Surg. 2019 Jan;54:60-65. doi: 10.1016/j.avsg.2018.08.073. Epub 2018 Sep 11.
Extracorporeal membrane oxygenation (ECMO) is an important life-saving modality for patients with cardiopulmonary failure. Vascular complications, including clinically significant limb ischemia, may occur as a result of femoral artery cannulation for venoarterial (VA) ECMO. This study examines our institutional experience with femoral VA ECMO and the development of ipsilateral limb ischemia.
We performed a retrospective review of all consecutive patients undergoing femoral VA ECMO between 2011 and 2016. The primary endpoint was clinical evidence of limb-threatening ischemia. Multivariate logistic regression analysis was used to identify predictors for limb ischemia after cannulation.
Between March 2011 and September 2016, 154 patients underwent femoral cannulation for VA ECMO. Overall in-hospital mortality was 59.7%. Clinically significant ipsilateral limb ischemia occurred in 34 (22%) patients; 7 required four-compartment fasciotomy, and 3 of these patients required amputation. On univariate analysis, a history of pulmonary disease, peripheral arterial disease, and stroke or transient ischemic attack was significantly associated with clinical limb ischemia. On multivariate analysis, younger age (odds ratio [OR], 0.96; 95% confidence interval [CI], 0.93-0.99), diabetes (OR, 2.77; 95% CI, 1.08-7.12), pulmonary disease (OR, 3.86; 95% CI, 1.38-10.78), and peripheral arterial disease (OR, 13.68; CI, 2.75-68.01) were associated with limb ischemia. Lack of prophylactic distal perfusion catheter and arterial cannula size were not independently associated with limb ischemia.
Femoral ECMO cannulation can be associated with significant limb ischemia necessitating surgical intervention. Younger patients, as well as those with a history of diabetes, pulmonary disease, and peripheral arterial disease, may be at increased risk for this complication.
体外膜肺氧合(ECMO)是治疗心肺衰竭患者的一种重要的挽救生命的方式。因股动脉插管进行静脉 - 动脉(VA)ECMO治疗可能会出现血管并发症,包括具有临床意义的肢体缺血。本研究探讨了我们机构在股动脉VA ECMO治疗方面的经验以及同侧肢体缺血的发生情况。
我们对2011年至2016年间所有连续接受股动脉VA ECMO治疗的患者进行了回顾性研究。主要终点是肢体威胁性缺血的临床证据。采用多因素逻辑回归分析来确定插管后肢体缺血的预测因素。
2011年3月至2016年9月期间,154例患者接受了股动脉插管进行VA ECMO治疗。总体住院死亡率为59.7%。34例(22%)患者出现了具有临床意义的同侧肢体缺血;7例需要进行四室筋膜切开术,其中3例患者需要截肢。单因素分析显示,肺部疾病史、外周动脉疾病史以及中风或短暂性脑缺血发作与临床肢体缺血显著相关。多因素分析显示,年龄较小(比值比[OR],0.96;95%置信区间[CI],0.93 - 0.99)、糖尿病(OR,2.77;95% CI,1.08 - 7.12)、肺部疾病(OR,3.86;95% CI,1.38 - 10.78)和外周动脉疾病(OR,13.68;CI,2.75 - 68.01)与肢体缺血相关。缺乏预防性远端灌注导管和动脉插管尺寸与肢体缺血无独立相关性。
股动脉ECMO插管可能会导致严重的肢体缺血,需要进行手术干预。年轻患者以及有糖尿病、肺部疾病和外周动脉疾病史的患者可能发生这种并发症的风险更高。